Induced Pluripotent Stem Cells (iPSCs) Market Report

Global and China Induced Pluripotent Stem Cells (iPSCs) Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 06, 2022
  • PAGES：227
  • REPORT CODE：GMM1441182
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Induced Pluripotent Stem Cells (iPSCs) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sumitomo Dainippon Pharma

    • Ncardia

    • ReproCELL

    • Fate Therapeutics, Inc

    • Cell Inspire Biotechnology

    • Pluricell Biotech

    • Astellas Pharma Inc

    • Fujifilm Holding Corporation (CDI)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Human iPSCs

    • Mouse iPSCs

    Application:

    • Academic Research

    • Drug Development and Discovery

    • Toxicity Screening

    • Regenerative Medicine

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Induced Pluripotent Stem Cells (iPSCs) Industry Overview

      • 1.1.1 Induced Pluripotent Stem Cells (iPSCs) Market Scope and Market Segments

      • 1.1.2 Induced Pluripotent Stem Cells (iPSCs) Industry Characteristics

      • 1.1.3 Global and China Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Induced Pluripotent Stem Cells (iPSCs) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Human iPSCs

      • 1.2.2 Mouse iPSCs

    • 1.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Academic Research

      • 1.3.2 Drug Development and Discovery

      • 1.3.3 Toxicity Screening

      • 1.3.4 Regenerative Medicine

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Induced Pluripotent Stem Cells (iPSCs) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Induced Pluripotent Stem Cells (iPSCs) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Induced Pluripotent Stem Cells (iPSCs) Industry PEST Analysis

    • 2.3 Induced Pluripotent Stem Cells (iPSCs) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Induced Pluripotent Stem Cells (iPSCs) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Induced Pluripotent Stem Cells (iPSCs) Industry

    Chapter 3 Global and China Induced Pluripotent Stem Cells (iPSCs) Market, by Manufacturer

    • 3.1 Global and China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Induced Pluripotent Stem Cells (iPSCs) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Induced Pluripotent Stem Cells (iPSCs) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Induced Pluripotent Stem Cells (iPSCs) Market Top 3 Players

    Chapter 4 Global and China Induced Pluripotent Stem Cells (iPSCs) Market, by Type (2017-2028)

    • 4.1 Induced Pluripotent Stem Cells (iPSCs) Market Trend, by Type

    • 4.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Induced Pluripotent Stem Cells (iPSCs) Price Trend, by Type (2017-2028)

    • 4.3 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Induced Pluripotent Stem Cells (iPSCs) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Induced Pluripotent Stem Cells (iPSCs) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Induced Pluripotent Stem Cells (iPSCs) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Induced Pluripotent Stem Cells (iPSCs) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Induced Pluripotent Stem Cells (iPSCs) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 7.1 North America Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 7.2 North America Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    • 7.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Analysis and Forecast, by Country

      • 7.3.1 United States Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 8.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 8.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    • 8.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 9.1 APAC Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 9.2 APAC Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    • 9.3 APAC Induced Pluripotent Stem Cells (iPSCs) Market Analysis and Forecast, by Country

      • 9.3.1 China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Analysis

    • 10.1 Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market, by Type

    • 10.2 Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market, by Application

    • 10.3 Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Induced Pluripotent Stem Cells (iPSCs) Company Profiles

      • 11.1 Sumitomo Dainippon Pharma

        • 11.1.1 Sumitomo Dainippon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.1.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Ncardia

        • 11.2.1 Ncardia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 ReproCELL

        • 11.3.1 ReproCELL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.3.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Fate Therapeutics, Inc

        • 11.4.1 Fate Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.4.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Cell Inspire Biotechnology

        • 11.5.1 Cell Inspire Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.5.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pluricell Biotech

        • 11.6.1 Pluricell Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Astellas Pharma Inc

        • 11.7.1 Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.7.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Fujifilm Holding Corporation (CDI)

        • 11.8.1 Fujifilm Holding Corporation (CDI) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Profiles, Application and Specification

        • 11.8.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Induced Pluripotent Stem Cells (iPSCs) Industry Investment Prospect and Risk Assessment

    • 12.1 Induced Pluripotent Stem Cells (iPSCs) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Induced Pluripotent Stem Cells (iPSCs) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Production Value and Growth Rate (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production Value and Growth Rate (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Human iPSCs (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Mouse iPSCs (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Academic Research (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Drug Development and Discovery (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Toxicity Screening (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Market Size and Growth Rate of Regenerative Medicine (2017-2028)

    • Figure North America Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Induced Pluripotent Stem Cells (iPSCs) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Induced Pluripotent Stem Cells (iPSCs) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Induced Pluripotent Stem Cells (iPSCs) Market Share, by Manufacturer in 2021

    • Figure Global and China Induced Pluripotent Stem Cells (iPSCs) Market Share, by Manufacturer in 2022

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Type (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Value, by Type (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Value Share, by Type (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Price Trend, by Type (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Type (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Value, by Type (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Value Share, by Type (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Price Trend, by Type (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Application (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Value, by Application (2017-2028)

    • Table Global Induced Pluripotent Stem Cells (iPSCs) Sales Value Share, by Application (2017-2028)

    • Figure Global Induced Pluripotent Stem Cells (iPSCs) Sales Value Share, by Application (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Application (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Value, by Application (2017-2028)

    • Table China Induced Pluripotent Stem Cells (iPSCs) Sales Value Share, by Application (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Value Share, by Application (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Production, Import, Consumption and Export (2017-2022)

    • Table North America Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Type (2017-2028)

    • Table North America Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Figure North America Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Table North America Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Application (2017-2028)

    • Table North America Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure North America Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure United States Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Table Europe Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Type (2017-2028)

    • Table Europe Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Table Europe Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Application (2017-2028)

    • Table Europe Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure UK Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure France Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure France Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Table APAC Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Type (2017-2028)

    • Table APAC Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Table APAC Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Application (2017-2028)

    • Table APAC Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure China Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure India Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure India Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Induced Pluripotent Stem Cells (iPSCs) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Induced Pluripotent Stem Cells (iPSCs) Sales Value and Growth Rate (2017-2028)

    • Table Sumitomo Dainippon Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sumitomo Dainippon Pharma Product Profiles, Application and Specification

    • Table Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ncardia Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ncardia Product Profiles, Application and Specification

    • Table Ncardia Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ReproCELL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ReproCELL Product Profiles, Application and Specification

    • Table ReproCELL Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fate Therapeutics, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fate Therapeutics, Inc Product Profiles, Application and Specification

    • Table Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cell Inspire Biotechnology Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cell Inspire Biotechnology Product Profiles, Application and Specification

    • Table Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pluricell Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pluricell Biotech Product Profiles, Application and Specification

    • Table Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Inc Product Profiles, Application and Specification

    • Table Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fujifilm Holding Corporation (CDI) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fujifilm Holding Corporation (CDI) Product Profiles, Application and Specification

    • Table Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US